Solid Biosciences Inc. Common Stock
Symbol: SLDB (NASDAQ)
Company Description:
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
- Today's Open: $2.75
- Today's High: $2.785
- Today's Low: $2.75
- Today's Volume: 349
- Yesterday Close: $2.7
- Yesterday High: $3
- Yesterday Low: $2.681
- Yesterday Volume: 1.49M
- Last Min Volume: 0
- Last Min High: $2.783
- Last Min Low: $2.78
- Last Min VWAP: $0
- Name: Solid Biosciences Inc. Common Stock
- Website: https://www.solidbio.com
- Listed Date: 2018-01-25
- Location: CHARLESTOWN, MA
- Market Status: Active
- CIK Number: 0001707502
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $197.66M
- Round Lot: 100
- Outstanding Shares: 77.52M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-05-15 | 8-K | View |
2025-05-15 | 424B5 | View |
2025-05-15 | S-3 | View |
2025-05-15 | SCHEDULE 13G/A | View |
2025-05-15 | 10-Q | View |
2025-05-12 | SCHEDULE 13G | View |
2025-04-25 | ARS | View |
2025-04-25 | DEFA14A | View |
2025-04-25 | DEF 14A | View |
2025-04-17 | SCHEDULE 13G/A | View |
2025-04-11 | PRE 14A | View |
2025-04-08 | 4 | View |
2025-03-14 | EFFECT | View |
2025-03-14 | EFFECT | View |
2025-03-13 | 4 | View |
2025-03-12 | CORRESP | View |
2025-03-12 | CORRESP | View |
2025-03-11 | UPLOAD | View |
2025-03-11 | UPLOAD | View |
2025-03-06 | S-3 | View |